SAA2 and cardiovascular disorder: Cai et al. [90] reported that i.p. injection of recombinant human SAA in apoE-/- promoted endothelial inflammation and dysfunction, which was associated with cardiovascular disease and renal pathologies; however, these effects were not observed when SAA was injected with HDL [90].